Revenue · 2011–2025
Vertex Pharmaceuticals revenue
$12.0B+8.9% · FY2025
Vertex Pharmaceuticals (VRTX) reported $12.0B in revenue for fiscal 2025, +8.9% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $12.0B | +8.9% | Open → |
| FY20242024-12-31 | $11.0B | +11.7% | Open → |
| FY20232023-12-31 | $9.9B | +10.5% | Open → |
| FY20222022-12-31 | $8.9B | +17.9% | Open → |
| FY20212021-12-31 | $7.6B | +22.1% | Open → |
| FY20202020-12-31 | $6.2B | +49.1% | Open → |
| FY20192019-12-31 | $4.2B | +36.6% | Open → |
| FY20182018-12-31 | $3.0B | +22.5% | Open → |
| FY20172017-12-31 | $2.5B | +46.2% | Open → |
| FY20162016-12-31 | $1.7B | +64.9% | Open → |
| FY20152015-12-31 | $1.0B | +77.9% | Open → |
| FY20142014-12-31 | $580M | −52.1% | Open → |
| FY20132013-12-31 | $1.2B | −20.6% | Open → |
| FY20122012-12-31 | $1.5B | +8.3% | Open → |
| FY20112011-12-31 | $1.4B | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +16.5%
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Vertex Pharmaceuticals revenue |url=https://companiesranked.com/en/company/vertex-pharmaceuticals/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Vertex Pharmaceuticals revenue. CompaniesRanked. https://companiesranked.com/en/company/vertex-pharmaceuticals/revenueBibTeX
@misc{companiesranked-en-company-vertex-pharmaceuticals-revenue-2026,
author = {{CompaniesRanked}},
title = {{Vertex Pharmaceuticals revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/vertex-pharmaceuticals/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000875320-26-000056 · February 13, 2026
{{cite web |title=Vertex Pharmaceuticals revenue — 10-K (0000875320-26-000056) |url=https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/vrtx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-13}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.